Tolero Pharmaceuticals

Tolero Pharmaceuticals

Pharmaceuticals, 3900 N Traverse MTN BLVD, Salt Lake City, Utah, 84043, United States, 11-50 Employees

toleropharma.com

  • twitter
  • LinkedIn

phone no Phone Number: +19*********

Who is TOLERO PHARMACEUTICALS

Tolero Pharmaceuticals is a clinical stage biopharmaceutical company developing treatments to improve and extend the lives of patients with serious oncological and hematological diseases....

Read More

map
  • 3900 N Traverse MTN BLVD, Salt Lake City, Utah, 84043, United States Headquarters: 3900 N Traverse MTN BLVD, Salt Lake City, Utah, 84043, United States
  • 2011 Date Founded: 2011
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from TOLERO PHARMACEUTICALS

Tolero Pharmaceuticals Org Chart and Mapping

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Tolero Pharmaceuticals

Answer: Tolero Pharmaceuticals's headquarters are located at 3900 N Traverse MTN BLVD, Salt Lake City, Utah, 84043, United States

Answer: Tolero Pharmaceuticals's phone number is +19*********

Answer: Tolero Pharmaceuticals's official website is https://toleropharma.com

Answer: Tolero Pharmaceuticals's revenue is $25 Million to $50 Million

Answer: Tolero Pharmaceuticals's SIC: 2834

Answer: Tolero Pharmaceuticals's NAICS: 325412

Answer: Tolero Pharmaceuticals has 11-50 employees

Answer: Tolero Pharmaceuticals is in Pharmaceuticals

Answer: Tolero Pharmaceuticals contact info: Phone number: +19********* Website: https://toleropharma.com

Answer: Tolero Pharmaceuticals is a clinical stage biopharmaceutical company developing treatments to improve and extend the lives of patients with serious oncological and hematological diseases. Our diverse pipeline targets important biological drivers of blood disorders to treat leukemias and anemia as well as important targets of drug resistance and transcriptional control.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access